Brief: Biomerieux Receives US FDA 510(K) Clearance And Ivdr CE Marking For Vitek Pro
BRIEF-Biomerieux Receives US FDA 510(K) Clearance And Ivdr CE Marking For Vitek Pro Nov 10 (Reuters) - Biomerieux SA BIOX.PA:
RECEIVES U.S. FDA 510(K) CLEARANCE AND IVDR CE MARKING FOR VITEK PRO
COMMERCIAL LAUNCH OF SOLUTION IS PLANNED TO BEGIN IN Q1 OF 2027
EXPECTS TO PROGRESSIVELY EXPAND AVAILABILITY ACROSS OTHER REGIONS WORLDWIDE IN Q2 2027 TO REPLACE VITEK 2 AND VITEK XL SYSTEMS
Source text: [ID:]
Further company coverage: BIOX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;;))
Recent news on Biomerieux SA
See all newsBrief: Biomerieux Receives US FDA 510(K) Clearance And Ivdr CE Marking For Vitek Pro
Brief: bioMerieux Receives FDA Clearance For Latest Versions Of Biofire® Filmarray
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Europe Research Roundup: Acceler8 Ventures, Hermes, Soitec
BioMerieux shares rise after Q3 sales beat